Healthcare - Biotechnology - NYSE - US
$ 6.37
-12.9 %
$ 367 M
Market Cap
-0.35
P/E
BALANCE SHEET
1.67 B
ASSETS
568 M
LIABILITIES
1.1 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Ginkgo Bioworks Holdings, Inc.
| Current Assets | 1 B |
| Cash & Short-Term Investments | 944 M |
| Receivables | 31.7 M |
| Other Current Assets | 25.9 M |
| Non-Current Assets | 664 M |
| Long-Term Investments | 78.6 M |
| PP&E | 397 M |
| Other Non-Current Assets | 188 M |
| Current Liabilities | 164 M |
| Accounts Payable | 9.32 M |
| Short-Term Debt | 19.9 M |
| Other Current Liabilities | 135 M |
| Non-Current Liabilities | 404 M |
| Long-Term Debt | 222 M |
| Other Non-Current Liabilities | 182 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2001 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 944.1 | 1 315.8 | 1 550.0 | 380.8 | 495.3 | 1 315.8 |
| Short Term Investments | (0.7) | 0 | 0 | 0 | 0 | 0 |
| Receivables | 31.7 | 82.5 | 149.9 | 21.9 | 7.7 | 80.9 |
| Inventory | 46 K | 4.4 | 3.4 | 2.7 | 0 | 4.4 |
| Other Current Assets | 25.9 | 47.5 | 19.8 | 21.1 | 9.0 | 49.0 |
| Total Current Assets | 1 001.7 | 1 450.1 | 1 723.0 | 426.5 | 511.9 | 1 450.1 |
| PP&E | 397.2 | 715.5 | 145.8 | 121.4 | 63.1 | 715.5 |
| Intangible Assets | 82.7 | 111.0 | 21.6 | 3.3 | 3.8 | 111.0 |
| Goodwill | 49.2 | 60.2 | 21.3 | 1.9 | 1.9 | 60.2 |
| Long Term Investments | 78.6 | 113.7 | 115.2 | 103.1 | 107.3 | 0 |
| Other Long Term Assets | 55.8 | 88.7 | 44.0 | 5.6 | 9.3 | 202.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 665.3 | 2 539.3 | 2 071.0 | 675.2 | 697.3 | 2 539.3 |
| LIABILITIES | ||||||
| Accounts Payable | 9.3 | 10.5 | 8.2 | 13.9 | 2.4 | 10.5 |
| Short Term Debt | 19.9 | 29.3 | 0.7 | 0.5 | 0.6 | 0 |
| Other Current Liabilities | 86.1 | 85.4 | 92.6 | 30.0 | 37.0 | 114.7 |
| Total Current Liabilities | 163.9 | 173.0 | 134.8 | 73.2 | 40.1 | 173.0 |
| Long Term Debt | 221.8 | 413.3 | 22.3 | (108.5) | 16.8 | 413.3 |
| Deferred Tax Income | 0 | 0 | 154.6 | 12.7 | 0 | 0 |
| Other Liabilities | 24.4 | 42.1 | 190.6 | (9.6) | 138.6 | 42.1 |
| Total Liabilities | 568.2 | 803.0 | 503.6 | 205.1 | 195.5 | 803.0 |
| EQUITY | ||||||
| Common Stock | 0.2 | 0.2 | 0.2 | 0.1 | 79 K | 0.2 |
| Retained Earnings | (5 290.5) | (4 397.7) | (2 297.9) | (467.9) | (341.3) | (4 397.7) |
| Other Accumulative Comprehensive Income/Loss | 1.5 | (2.6) | (1.7) | 0 | 0 | 0 |
| Total Equity | 1 097.2 | 1 736.3 | 1 567.4 | 470.1 | 501.9 | 1 736.3 |
| Total Liabilities and Equity | 1 665.3 | 2 539.3 | 2 071.0 | 675.2 | 697.3 | 2 539.3 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 48.6 | 42.0 | 34.0 | 1 485.1 | 1 485.1 | 0 |